Isomorphic Labs

aid: isomorphic-labs
name: Isomorphic Labs
description: Isomorphic Labs is a London-based AI-first drug discovery company spun out of Google DeepMind in 2021 and operating
  as an Alphabet subsidiary. Founded and led by Sir Demis Hassabis, the company applies frontier AI — including derivatives
  of the Nobel-winning AlphaFold system and its proprietary Unified Drug Design Engine — to accelerate the design of small-molecule
  and biologic therapeutics across oncology, immunology, and other therapeutic areas. The Drug Design Engine is positioned
  as a target- and disease-agnostic, multi-modality platform that combines predictive and generative models with a curated
  proprietary life-science "Dataverse" and large-scale GPU infrastructure. Isomorphic Labs monetises through strategic pharmaceutical
  research collaborations — disclosed deals include Novartis (January 2024, expanded February 2025), Eli Lilly, and Johnson
  & Johnson (January 2026) — and through its own internal therapeutic pipeline. The company closed a $600M external Series
  B investment round in March 2025. Isomorphic Labs does not operate a public developer API, SDK, or open-source release of
  its Drug Design Engine; external researcher access to AlphaFold-family models is provided separately by Google DeepMind
  via the free AlphaFold Server (alphafoldserver.com) for non-commercial use, and via the open-source AlphaFold 3 inference
  code released by DeepMind. The Isomorphic Labs GitHub organisation hosts only a small number of forks of internal Kubernetes
  and configuration-management tooling.
type: Index
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
position: Provider
access: 3rd-Party
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/isomorphic-labs.png
tags:
- Artificial Intelligence
- Drug Discovery
- Pharmaceutical
- Life Sciences
- Biotechnology
- Computational Biology
- Protein Structure
- AlphaFold
- Generative AI
- Foundation Models
- Small Molecules
- Biologics
- Oncology
- Immunology
- Alphabet
- DeepMind
url: https://raw.githubusercontent.com/api-evangelist/isomorphic-labs/refs/heads/main/apis.yml
created: '2026-05-24'
modified: '2026-05-24'
specificationVersion: '0.20'
apis: []
common:
- type: DomainSecurity
  url: security/isomorphic-labs-domain-security.yml
- type: Website
  url: https://www.isomorphiclabs.com
- type: OurTech
  url: https://www.isomorphiclabs.com/our-tech
- type: Partnerships
  url: https://www.isomorphiclabs.com/partnerships
- type: OurTeam
  url: https://www.isomorphiclabs.com/our-team
- type: LifeAtIso
  url: https://www.isomorphiclabs.com/life-at-iso
- type: Careers
  url: https://www.isomorphiclabs.com/work-with-us
- type: JobOpenings
  url: https://www.isomorphiclabs.com/job-openings
- type: Newsroom
  url: https://www.isomorphiclabs.com/news
- type: AlphaFoldServer
  url: https://alphafoldserver.com
- type: AlphaFold3Code
  url: https://github.com/google-deepmind/alphafold3
- type: GitHubOrganization
  url: https://github.com/isomorphiclabs
- type: Twitter
  url: https://twitter.com/IsomorphicLabs
- type: LinkedIn
  url: https://www.linkedin.com/company/isomorphic-labs
- type: PressContact
  url: mailto:press@isomorphiclabs.com
- type: PartneringContact
  url: mailto:partnering@isomorphiclabs.com
- type: GeneralContact
  url: mailto:connecting@isomorphiclabs.com
- url: https://www.isomorphiclabs.com/news
  type: Blog
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com